Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling
Abstract Background The differentiation of pancreatic ductal adenocarcinoma (PDAC) could be associated with prognosis and may influence the choices of clinical management. No applicable methods could reliably predict the tumor differentiation preoperatively. Thus, the aim of this study was to compar...
Main Authors: | Shi Wen, Bohan Zhan, Jianghua Feng, Weize Hu, Xianchao Lin, Jianxi Bai, Heguang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3703-9 |
Similar Items
-
Correlations of miR-1290 and miR-191-5p with laboratory parameters
as a useful test to differentiate pancreatic cancer from chronic pancreatitis: preliminary study
by: Małgorzata Guz, et al.
Published: (2023-06-01) -
Serum Metabonomics Study of Difference in Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on LC-MS
by: HUANG Xiangping, et al.
Published: (2023-10-01) -
Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study
by: Naohiro Kato, et al.
Published: (2023-05-01) -
Expression of Calretinin, Marker of Mesothelial Differentiation, in Pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall
by: Gokce ASKAN, et al.
Published: (2021-05-01) -
Non-Invasive Monitoring of Stromal Biophysics with Targeted Depletion of Hyaluronan in Pancreatic Ductal Adenocarcinoma
by: Ezekiel Maloney, et al.
Published: (2019-06-01)